Background Close to 800 million people in the world are at risk of schistosomiasis, 85 per cent of whom live in Africa. Recent studies have indicated that female genital schistosomiasis might increase the risk of human immunodeficiency virus (HIV) infection. The aim of this study is to quantify and analyse the characteristics of the vasculature surrounding Schistosoma haematobium ova in the female genital mucosa. Methodology/Principal Findings Cervicovaginal biopsies with S. haematobium ova (n = 20) and control biopsies (n = 69) were stained with immunohistochemical blood vessel markers CD31 and von Willebrand Factor (vWF), which stain endothelial cells in capillary buds and established blood vessels respectively. Haematoxylin and eosin (HE) were applied for histopathological assessment. The tissue surrounding S. haematobium ova had a higher density of established blood vessels stained by vWF compared to healthy controls (p = 0.017). Immunostain to CD31 identified significantly more granulation tissue surrounding viable compared to calcified ova (p = 0.032), and a tendency to neovascularisation in the tissue surrounding viable ova compared to healthy cervical mucosa (p = 0.052). Conclusions/Significance In this study female genital mucosa with S. haematobium ova was significantly more vascularised compared to healthy cervical tissue. Viable parasite ova were associated with granulation tissue rich in sprouting blood vessels. Although the findings of blood vessel proliferation in this study may be a step to better understand the implications of S. haematobium infection, further studies are needed to explore the biological, clinical and epidemiological features of female genital schistosomiasis and its possible influence on HIV susceptibility.
References
[1]
Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411–425. doi: 10.1016/S1473-3099(06)70521-7
[2]
UNAIDS (2008) Report on the global AIDS epidemic.
[3]
WHO (2002) Schistosomiasis. Epidemiological data/Geographical distribution.
[4]
Kjetland EF, Ndhlovu PD, Gomo E, Mduluza T, Midzi N, et al. (2006) Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 20: 593–600. doi: 10.1097/01.aids.0000210614.45212.0a
[5]
Asin SN, Eszterhas SK, Rollenhagen C, Heimberg AM, Howell AL (2009) HIV type 1 infection in women: increased transcription of HIV type 1 in ectocervical tissue explants. J Infect Dis 200: 965–972. doi: 10.1086/605412
[6]
Gelfand M, Ross MD, Blair DM, Weber MC (1971) Distribution and extent of schistosomiasis in female pelvic organs, with special reference to the genital tract, as determined at autopsy. Am J Trop Med Hyg 20: 846–849.
[7]
Kjetland EF, Ndhlovu PD, Mduluza T, Gomo E, Gwanzura L, et al. (2005) Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean women. Am J Trop Med Hyg 72: 311–319.
[8]
Kjetland EF, Poggensee G, Helling-Giese G, Richter J, Sjaastad A, et al. (1996) Female genital schistosomiasis due to Schistosoma haematobium. Clinical and parasitological findings in women in rural Malawi. Acta Trop 62: 239–255. doi: 10.1016/S0001-706X(96)00026-5
[9]
Poggensee G, Kiwelu I, Weger V, Goppner D, Diedrich T, et al. (2000) Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in northern Tanzania. J Infect Dis 181: 1210–1213. doi: 10.1086/315345
[10]
Freedman DO, Ottesen EA (1988) Eggs of Schistosoma mansoni stimulate endothelial cell proliferation in vitro. J Infect Dis 158: 556–562. doi: 10.1093/infdis/158.3.556
[11]
Loeffler DA, Lundy SK, Singh KP, Gerard HC, Hudson AP, et al. (2002) Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells. J Infect Dis 185: 1650–1656. doi: 10.1086/340416
[12]
Chen XS, Yin YP, Tucker JD, Gao X, Cheng F, et al. (2007) Detection of acute and established HIV infections in sexually transmitted disease clinics in Guangxi, China: Implications for screening and prevention of HIV infection. J Infect Dis 196: 1654–1661. doi: 10.1086/522008
[13]
Feldmeier H, Krantz I, Poggensee G (1995) Female genital schistosomiasis: a neglected risk factor for the transmission of HIV? Trans R Soc Trop Med Hyg 89: 237. doi: 10.1016/0035-9203(95)90512-X
[14]
Helling-Giese G, Sjaastad A, Poggensee G, Kjetland EF, Richter J, et al. (1996) Female genital schistosomiasis (FGS): relationship between gynecological and histopathological findings. Acta Trop 62: 257–267. doi: 10.1016/S0001-706X(96)00027-7
[15]
Wright ED, Chiphangwi J, Hutt MS (1982) Schistosomiasis of the female genital tract. A histopathological study of 176 cases from Malawi. Trans R Soc Trop Med Hyg 76: 822–829. doi: 10.1016/0035-9203(82)90118-3
[16]
Berry A (1966) A cytopathological and histopathological study of bilharziasis of the female genital tract. J Pathol Bacteriol 91: 325–338. doi: 10.1002/path.1700910206
[17]
Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K, et al. (1997) Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer. Clin Cancer Res 3: 2485–2492.
[18]
Lenzi HL, Sobral AC, Lenzi JA (1988) Participation of endothelial cells in murine schistosomiasis. Braz J Med Biol Res 21: 999–1003.
[19]
Friedberg D, Berry AV, Schneider J, Fripp PJ (1991) Schistosomiasis of the female genital tract. S Afr Med J 80: Suppl2–15.
[20]
Williams AO (1967) Pathology of schistosomiasis of the uterine cervix due to S. haematobium. Am J Obstet Gynecol 98: 784–791.
[21]
Edington GM, von Lichtenberg F, Nwabuebo I, Taylor JR, Smith JH (1970) Pathologic effects of schistosomiasis in Ibadan, Western State of Nigeria. I. Incidence and intensity of infection; distribution and severity of lesions. Am J Trop Med Hyg 19: 982–995.
[22]
Christie JD, Crouse D, Pineda J, Anis-Ishak E, Smith JH, et al. (1986) Patterns of Schistosoma haematobium egg distribution in the human lower urinary tract. I. Noncancerous lower urinary tracts. Am J Trop Med Hyg 35: 743–751.
[23]
Charlewood GP, Shippel S, Renton H (1949) Schistosomiasis in gynaecology. J Obstet Gynaecol Br Emp 56: 367–385. doi: 10.1111/j.1471-0528.1949.tb07107.x
[24]
Ghoneim MA (2002) Bilharziasis of the genitourinary tract. BJU Int 89: Suppl 122–30. doi: 10.1046/j.1464-4096.2001.138.138.x
[25]
Badawy AH (1962) Schistosomiasis of the cervix. Br Med J 1: 369–372. doi: 10.1136/bmj.1.5275.369
[26]
Nash TE, Cheever AW, Ottesen EA, Cook JA (1982) Schistosome infections in humans: perspectives and recent findings. NIH conference. Ann Intern Med 97: 740–754. doi: 10.7326/0003-4819-97-5-740
[27]
King CH, Dickman K, Tisch DJ (2005) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561–1569. doi: 10.1016/S0140-6736(05)66457-4
[28]
Jong E, Louw S, Meijers JC, de Kruif MD, ten Cate H, et al. (2009) The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy. AIDS Patient Care STDS 23: 1001–1007. doi: 10.1089/apc.2009.0173
[29]
Andrade ZA, Santana TS (2010) Angiogenesis and schistosomiasis. Mem Inst Oswaldo Cruz 105: 436–439. doi: 10.1590/S0074-02762010000400013
[30]
WHO (2009) WHO working group on urogenital schistosomiasis and HIV transmission 1–2 October 2009.
[31]
Bobardt MD, Salmon P, Wang L, Esko JD, Gabuzda D, et al. (2004) Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion. J Virol 78: 6567–6584. doi: 10.1128/JVI.78.12.6567-6584.2004
[32]
Pomerantz RJ, de la Monte SM, Donegan SP, Rota TR, Vogt MW, et al. (1988) Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med 108: 321–327. doi: 10.7326/0003-4819-108-3-321
[33]
Rhodes RH, Ward JM (1989) Immunohistochemistry of human immunodeficiency virus in the central nervous system and an hypothesis concerning the pathogenesis of AIDS meningoencephalomyelitis. Prog AIDS Pathol 1: 167–179.
[34]
Miller CJ, Alexander NJ, Vogel P, Anderson J, Marx PA (1992) Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J Med Primatol 21: 64–68.
[35]
Myer L, Wright TC Jr, Denny L, Kuhn L (2006) Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa. Sex Transm Dis 33: 683–687. doi: 10.1097/01.olq.0000216026.67352.f9
[36]
Davis CW, Doms RW (2004) HIV transmission: closing all the doors. J Exp Med 199: 1037–1040. doi: 10.1084/jem.20040426
[37]
McManus DP, Loukas A (2008) Current status of vaccines for schistosomiasis. Clin Microbiol Rev 21: 225–242. doi: 10.1128/CMR.00046-07
[38]
Kjetland EF, Ndhlovu PD, Kurewa EN, Midzi N, Gomo E, et al. (2008) Prevention of gynecologic contact bleeding and genital sandy patches by childhood anti-schistosomal treatment. Am J Trop Med Hyg 79: 79–83.
